3 Boomerang Capital Invests in Bio-Response Solutions
March 25, 2025
3 Boomerang Capital has made a strategic growth investment in Bio-Response Solutions to provide capital and resources to accelerate the company’s expansion in regulated biomedical waste management. The investment will support scaling operations and expanding Bio-Response’s Aquamation and scientific sterilization equipment into funeral homes, veterinary clinics, and high-containment laboratory end markets.
- Buyers
- 3 Boomerang Capital
- Targets
- Bio-Response Solutions
- Industry
- Medical Devices
- Location
- Indiana, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
3 Boomerang Capital Growth Recapitalization of Enjoin, LLC
November 21, 2024
Healthcare Services
3 Boomerang Capital completed a majority growth recapitalization of Enjoin, LLC, a Clinical Documentation Integrity (CDI) and mid-revenue cycle solutions provider for hospitals and health systems. The investment will supply strategic resources and capital to expand Enjoin's tech-enabled CDI capabilities and support continued growth across healthcare provider markets.
-
Elevation Labs Acquires Boomerang Laboratories
April 1, 2024
Manufacturing
Elevation Labs, a Knox Lane‑backed contract manufacturer of beauty and personal care products, has acquired Boomerang Laboratories, a Spring Park, Minnesota-based formulator and copacker. The deal adds a third production location and additional capacity to Elevation's existing facilities, expanding its formulation, filling and packaging capabilities to better serve brand partners.
-
Covanta Acquires BIOLOGIC Environmental Services and Waste Solutions
August 29, 2022
Environmental Services
Covanta has acquired BIOLOGIC Environmental Services and Waste Solutions, a California-based regulated waste management firm, and will integrate Biologic's Northern and Southern California facilities into its portfolio. The deal expands Covanta's western U.S. footprint and adds regulated/medical and maritime waste handling capabilities to support its sustainable materials management strategy.
-
BroadOak Capital Partners and RCT Invest in Biolog, Inc.
May 12, 2022
Biotechnology
BroadOak Capital Partners and Research Corporation Technologies (RCT) made a growth capital investment in Biolog, Inc., a Hayward, California-based provider of cell-based microbial identification and phenotypic profiling technologies. As part of the recapitalization, Robert Wicke was named CEO and the company will use proceeds to advance its cellular analysis product portfolio and expand commercial adoption across pharmaceutical, academic, biotech and environmental markets.
-
Ampersand Capital Partners Invests in BioEcho Life Sciences
March 1, 2022
Biotechnology
Ampersand Capital Partners made a minority growth equity investment in Cologne-based BioEcho Life Sciences to support the company's global expansion, new product launches, and expansion of its direct salesforce. As part of the transaction Ampersand appointed Frank Witney and Arya Mehrabanzad to BioEcho's board; financial terms were not disclosed.
-
Guy & O'Neill Acquires Boomerang Laboratories
March 25, 2020
Consumer Products
Guy & O'Neill, Inc., a portfolio company of Centre Partners, has acquired Boomerang Laboratories, Inc., a Spring Park, Minnesota-based liquid-fill manufacturer of personal care and light-duty household cleaning products. The deal expands Guy & O'Neill's liquid-fill capacity and product breadth (Boomerang operates a 75,000 sq. ft. facility); financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.